Inhibikase Therapeutics, Inc. IKT
1.55 USD -0.13 (-7.74%)
At closeNov 10, 2026, 4:00 PM EST
1.55 0.00 0.00%
After hours · Nov 10, 4:00 PM ET
1.53 Day range 1.65
1.40 52-week range 2.61
- YTD
- -24.39%
- 1 year
- -2.52%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -53.35M | -28.59M | -20.09M | -18.13M | -14.77M | |
| -48.26M | -27.52M | -19.03M | -18.05M | -14.79M | |
| -0.49 | -1.16 | -3.16 | -4.28 | -4.86 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 139.22M | 56.49M | 9.17M | 7.19M | 40.75M | |
| 181.20M | 98.60M | 14.51M | 24.94M | 42.47M | |
| 8.30M | 3.73M | 3.53M | 3.90M | 4.05M | |
| 172.90M | 94.87M | 10.98M | 21.04M | 38.42M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -27.79M | -19.15M | -18.09M | -17.35M | -14.30M | |
| 2.05M | -37.00M | 11.66M | -16.01M | 0 | |
| 108.46M | 103.48M | 8.41M | -204.77K | 41.09M | |
| -13.40K | 0 | -14.24K | -243.25K | 0 | |
| 82.73M | 47.33M | 1.98M | -33.56M | 26.80M |